Release Date: 2022-03-15
Risk Factors and Treatment Options of Cancer- or Chemotherapy- Related Cognitive Disorders
Turan Karaoglu (Author)
Release Date: 2022-03-15
Media Type
PDF
Buy from
Price may vary by retailers
| Work Type | Book Chapter |
|---|---|
| Published in | A Handbook on Chemobrain with Molecular and Clinical Background |
| First Page | 63 |
| Last Page | 68 |
| DOI | https://doi.org/10.69860/nobel.9786053358985.9 |
| ISBN | 978-605-335-898-5 (PDF) |
| Language | ENG |
| Page Count | 6 |
| Copyright Holder | Nobel Tıp Kitabevleri |
| License | https://nobelpub.com/publish-with-us/copyright-and-licensing |
Turan Karaoglu (Author)
Dr., MD, Muğla Sıtkı Koçman University
https://orcid.org/0000-0002-6318-8560
Ahles TA. Brain vulnerability to chemotherapy toxicities. Psychooncol. 2012; 21:1141-8.
Bender C, Merriman J. Cancer and treatment-treated cognitive changes: what can we do now? What lies ahead? Oncology 2014; 28: 201379.
Boykoff N, Moieni M, Subramanian S. Confronting chemobrain: An in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Survivorship. 2009; 3: 223-32.
Danhauer SC, Addington EL, Sohl SJ, et al. Review of Yoga therapy during cancer treatment. Support Care Cancer. 2017; 25: 1357-72.
Ehlers DK, Aguinaga S, Cosman J, et al. The effects of physical activity and fatigue on cognitive performance in breast cancer survivors. Breast Cancer Res Treat. 2017; 165: 699-707.
El-Agamy SE, Abdel-Aziz AK, Esmat A, et al. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemther Pharmacol. 2019; 84: 1-14.
Ferguson RJ, Ahles TA. Chemotherapy associated cognitive impairment in patients with cancer and cancer survivors. Curr Neurol Neurosci Rep. 2003; 3: 215-22.
Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and following breast cancer treatment. CA Cancer J Clin. 2017; 67: 194-292.
Harris SE, Deary IJ. The genetics of cognitive ability and cognitive ageing in healthy older people. Trend Cogn Sci. 2011; 15: 388-94.
Jansen J, Miaskowski C, Dodd M, et al. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum. 2005; 32:1151-63.
Lenz ER, Suppe F, Gift AG, et al. Collaborative development of middle-range nursing theories: toward a theory of unpleasant symptoms. ANS Adv Nurs Sci.1995; 17: 1-13.
Levkovich I, Cohen M, Alon S, et al. Symptom cluster of emotional distress, fatigue,and cognitive difficulties among young and older breast cancer survivors:the mediating role of subjective stress. J Geriatr Oncol. 2018; 9: 469-75.
Munir F, Burrows J, Yarker J, et al. Women’s perceptions of chemotherapy-induced side effects on work ability: A focus group study. J Clin Nurs. 2010; 19: 1362-70.
Selamat MH, Loh SY, Mackenzie L, et al. Chemobrain experienced by breast cancer curvivors: A meta-ethnography study investigating research and care implications. PLoS One 2014; 9: e108002.
Sleight A. Coping with cancer-related cognitive dysfunction: a scoping review of the literature. Disabil Rehabil. 2016; 38: 400-8.
Small BJ, Sharp Rowson K, Walsh E, et al. Catechol-o-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 2011; 117: 1369-76.
Tanriverdi O, Yavuzsen T, Turhal S, et al. Depression and socio-economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Eur J Cancer Care (Engl). 2016; 25: 502-15.
Olson B, Marks DL. Pretreatment cancer-related cognitive impairment- mechanisms and outlook. Cancers 2019; 11: 687.
Wang XM, Walitt B, Saligan L, et al. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine 2015; 72: 86-96.
Zheng Y, Luo J, Bao P, et al. Long-term cognitive function change among breast cancer survivors. Breast Cancer Res Treat. 2014; 146: 599-609.
| onix_3.0::thoth | Thoth ONIX 3.0 |
|---|---|
| onix_3.0::project_muse | Project MUSE ONIX 3.0 |
| onix_3.0::oapen | OAPEN ONIX 3.0 |
| onix_3.0::jstor | JSTOR ONIX 3.0 |
| onix_3.0::google_books | Google Books ONIX 3.0 |
| onix_3.0::overdrive | OverDrive ONIX 3.0 |
| onix_2.1::ebsco_host | EBSCO Host ONIX 2.1 |
| csv::thoth | Thoth CSV |
| json::thoth | Thoth JSON |
| kbart::oclc | OCLC KBART |
| bibtex::thoth | Thoth BibTeX |
| doideposit::crossref | CrossRef DOI deposit |
| onix_2.1::proquest_ebrary | ProQuest Ebrary ONIX 2.1 |
| marc21record::thoth | Thoth MARC 21 Record |
| marc21markup::thoth | Thoth MARC 21 Markup |
| marc21xml::thoth | Thoth MARC 21 XML |
